官方服务：
资源简介：
Sixteen approved NSCLC drugs.
应用场景：
创建时间：
2017-08-19
相关数据集
Pulmonary Drugs Market Size, Trends and Forecast to 2030
Pulmonary Drugs Market to be valued at $77.31 Bn by 2030. Report: Industry Size, Y-o-Y Growth Rate, Epidemiology, Prevalence Rate
www.coherentmarketinsights.com110
PM01183 on SCLC cell lines (ChIP-Seq)
detect the impact of lurbinectedin on transciption factor binding Overall design: PM01183 on SCLC cell lines
NIAID Data Ecosystem40
Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells
Small Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy with a poor prognosis. Here, we focus on the neuroendocrine SCLC subtypes SCLC-A and SCLC-N, whose transcription addiction was
NIAID Data Ecosystem20
Detailed information of 22 candidate chemicals for SCLC.
a: These chemicals were reported to be related to SCLC in previous studies. b: These chemicals were excluded by further selection because their maximum interaction scores were smaller than 900 and the
NIAID Data Ecosystem70
Table1_Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis.XLS
Ferroptosis is a form of non-apoptotic and iron-dependent cell death originally identified in cancer cells. Recently, emerging evidence showed that ferroptosis-targeting therapy could be a novel promi
NIAID Data Ecosystem30
